1. Home
  2. BCLI vs LSH Comparison

BCLI vs LSH Comparison

Compare BCLI & LSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCLI
  • LSH
  • Stock Information
  • Founded
  • BCLI 2000
  • LSH 2018
  • Country
  • BCLI United States
  • LSH United States
  • Employees
  • BCLI N/A
  • LSH N/A
  • Industry
  • BCLI Biotechnology: Biological Products (No Diagnostic Substances)
  • LSH
  • Sector
  • BCLI Health Care
  • LSH
  • Exchange
  • BCLI Nasdaq
  • LSH NYSE
  • Market Cap
  • BCLI 7.9M
  • LSH 7.0M
  • IPO Year
  • BCLI N/A
  • LSH 2024
  • Fundamental
  • Price
  • BCLI $1.16
  • LSH $0.88
  • Analyst Decision
  • BCLI Strong Buy
  • LSH
  • Analyst Count
  • BCLI 1
  • LSH 0
  • Target Price
  • BCLI $30.00
  • LSH N/A
  • AVG Volume (30 Days)
  • BCLI 141.4K
  • LSH 55.1K
  • Earning Date
  • BCLI 05-15-2025
  • LSH 05-15-2025
  • Dividend Yield
  • BCLI N/A
  • LSH N/A
  • EPS Growth
  • BCLI N/A
  • LSH N/A
  • EPS
  • BCLI N/A
  • LSH N/A
  • Revenue
  • BCLI N/A
  • LSH $16,927,719.00
  • Revenue This Year
  • BCLI N/A
  • LSH N/A
  • Revenue Next Year
  • BCLI N/A
  • LSH N/A
  • P/E Ratio
  • BCLI N/A
  • LSH N/A
  • Revenue Growth
  • BCLI N/A
  • LSH 2.84
  • 52 Week Low
  • BCLI $0.72
  • LSH $0.88
  • 52 Week High
  • BCLI $10.05
  • LSH $5.37
  • Technical
  • Relative Strength Index (RSI)
  • BCLI 50.13
  • LSH N/A
  • Support Level
  • BCLI $1.12
  • LSH N/A
  • Resistance Level
  • BCLI $1.26
  • LSH N/A
  • Average True Range (ATR)
  • BCLI 0.14
  • LSH 0.00
  • MACD
  • BCLI 0.02
  • LSH 0.00
  • Stochastic Oscillator
  • BCLI 42.86
  • LSH 0.00

About BCLI Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

About LSH LAKESIDE HOLDING LTD

Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.

Share on Social Networks: